RxDoctor Payments Data

Charles Andrews

Internal Medicine · Newport Beach, CANPI 1750345955

Payments from drug & device makers

$6,119in general payments, 2019–2025

Across 375 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Pfizer$665
  • AstraZeneca$491
  • Lilly USA, LLC$489
  • Boehringer Ingelheim$450
  • Amgen$436
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$6,095100%
  • Education$230%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,119 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in Newport Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →